Filing Details
- Accession Number:
- 0001110803-14-000350
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-16 20:09:20
- Reporting Period:
- 2014-10-15
- Filing Date:
- 2014-10-16
- Accepted Time:
- 2014-10-16 20:09:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corp Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-15 | 2,000 | $43.37 | 25,146 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-15 | 225 | $146.33 | 24,921 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-15 | 1,123 | $147.81 | 23,798 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-15 | 652 | $148.46 | 23,146 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-10-15 | 2,000 | $0.00 | 2,000 | $43.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 225 shares sold ranging from $145.90 to $146.86 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,123 shares sold ranging from $147.12 to $148.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 652 shares sold ranging from $148.15 to $148.84 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
